Ninety percent of cancer-related deaths are due to metastatic (stage IV) disease, when the malignant cells spread throughout the body interfering with organ function leading to organ failure and death. Utilizing our unique, state-of-the-art cell-based technologies, Ixchel Scientific is developing interventions specifically against metastatic cancers.